Edition:
India

Koninklijke DSM NV (KDSKF.PK)

KDSKF.PK on OTC Markets Group

67.40USD
--
Change (% chg)

$0.00 (+0.00%)
Prev Close
$67.40
Open
--
Day's High
--
Day's Low
--
Volume
3
Avg. Vol
--
52-wk High
$67.40
52-wk Low
$63.60

KDSKF.PK

Chart for KDSKF.PK

About

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties. Its Performance... (more)

Overall

Beta: 0.79
Market Cap(Mil.): €11,475.13
Shares Outstanding(Mil.): 181.43
Dividend: 0.58
Yield (%): 2.81

Financials

  KDSKF.PK Industry Sector
P/E (TTM): 15.06 17.71 49.68
EPS (TTM): 4.20 -- --
ROI: 5.62 6.76 9.48
ROE: 13.12 10.48 12.49

BRIEF-Amyris says second tranche of $50 mln in a private placement days is being led by a $25-mln investment from Koninklijke​

* Amyris announces agreements for $50 million in second tranche of equity financing, exceeding previous target of $95 million

03 Aug 2017

UPDATE 2-DSM raises 2017 profit forecasts, shares jump

AMSTERDAM, Aug 1 Dutch speciality chemicals company DSM raised its profit forecast for 2017 on Tuesday after higher sales and tighter cost controls helped it report a better than expected 15 percent rise in second-quarter earnings.

01 Aug 2017

BRIEF-Aerie Pharmaceuticals enters into collaboration agreement with DSM

* Aerie Pharmaceuticals enters into collaboration agreement with DSM focused on technology to potentially deliver Aerie compounds to treat retinal diseases such as wet AMD

31 Jul 2017

BRIEF-Amyris enters into first product development, production agreement with Royal DSM

* Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule

17 Jul 2017

BRIEF-Beijing WKW Automotive Parts plans to buy stake in DSM Green Power Ltd

* Says it plans to buy 23 percent stake in DSM Green Power Ltd for 115 million yuan ($16.90 million)

10 Jul 2017

Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services

Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV, a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry. | Video

16 May 2017

Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services

Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV , a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry. | Video

15 May 2017

UPDATE 4-Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services

* Thermo Fisher is world's biggest maker of scientific instruments

15 May 2017

DSM to tender Patheon stake to Thermo Fisher

Dutch food supplement maker DSM will tender its stake in U.S. drug ingredient maker Patheon to Thermo Fisher Scientific , DSM said on Monday.

15 May 2017

UPDATE 1-DSM to tender Patheon stake to Thermo Fisher

May 15 Dutch food supplement maker DSM will tender its stake in U.S. drug ingredient maker Patheon to Thermo Fisher Scientific, DSM said on Monday.

15 May 2017

Earnings vs. Estimates